Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Cystadenocarcinoma, Serous

Known as: Cystadenocarcinoma, Serous [Disease/Finding], serous carcinoma, Serous Cystadenocarcinomas 
A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
P53 immunohistochemistry has evolved into an accurate surrogate reflecting the underlying TP53 mutation status of a tumor, and… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Ovarian cancer is the most lethal gynecologic malignancy. Efforts at early detection and new therapeutic approaches to reduce… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
  • Ernst Lengyel
  • The American journal of pathology
  • 2010
  • Corpus ID: 20398612
The biology of ovarian carcinoma differs from that of hematogenously metastasizing tumors because ovarian cancer cells primarily… Expand
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
The objective of this study was to identify and characterize a self-renewing subpopulation of human ovarian tumor cells (ovarian… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Proposed origins of pelvic serous carcinoma include the ovary, fallopian tube, and peritoneum. Prophylactic salpingo… Expand
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE We evaluated the efficacy and safety of bevacizumab in patients with platinum-resistant epithelial ovarian carcinoma (EOC… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
A proportion of adenocarcinomas in prophylactic adnexectomies (bilateral salpingo-oophorectomies [BSOs]) from women with BRCA… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
To compare the survival of women with uterine papillary serous carcinoma (UPSC) and clear cell carcinoma (CC) to those with grade… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
In this study, we evaluate a two-tier system for grading ovarian serous carcinoma. This system is based primarily on the… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Activating mutations in KRAS and in one of its downstream mediators, BRAF, have been identified in a variety of human cancers. To… Expand
  • figure 1
Is this relevant?